eslicarbazepine and Eosinophilia

eslicarbazepine has been researched along with Eosinophilia* in 1 studies

Other Studies

1 other study(ies) available for eslicarbazepine and Eosinophilia

Article	Year
Patch testing in a case of eslicarbazepine and carbamazepine induced cutaneous reaction. European annals of allergy and clinical immunology, 2018, Volume: 50, Issue:5 Anticonvulsants are among the drugs most commonly involved in cutaneous adverse drug reactions (CADRs). Eslicarbazepine is a new anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile. We report the clinical case of a woman who developed a skin rash on day 10 of eslicarbazepine with further exacerbation with eosinophilia on day 2 of carbamazepine. Epicutaneous tests were positive with eslicarbazepine. Topics: Allergens; Anticonvulsants; Carbamazepine; Dibenzazepines; Disease Progression; Drug Hypersensitivity; Eosinophilia; Exanthema; Female; Humans; Middle Aged; Patch Tests	2018

Article

Year

Patch testing in a case of eslicarbazepine and carbamazepine induced cutaneous reaction.

European annals of allergy and clinical immunology, 2018, Volume: 50, Issue:5

Anticonvulsants are among the drugs most commonly involved in cutaneous adverse drug reactions (CADRs). Eslicarbazepine is a new anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile. We report the clinical case of a woman who developed a skin rash on day 10 of eslicarbazepine with further exacerbation with eosinophilia on day 2 of carbamazepine. Epicutaneous tests were positive with eslicarbazepine.

Topics: Allergens; Anticonvulsants; Carbamazepine; Dibenzazepines; Disease Progression; Drug Hypersensitivity; Eosinophilia; Exanthema; Female; Humans; Middle Aged; Patch Tests

2018